1379P Margetuximab (M) with retifanlimab (R) in HER2+, PD-L1+ 1st-line unresectable/metastatic gastroesophageal adenocarcinoma (GEA): MAHOGANY cohort A
Daniel V.T. Catenacci,
H. Park,
Byoung Yong Shim,
S.T. Kim,
D-Y. Oh,
Alexander I. Spira,
Susanna V. Ulahannan,
Eric J. Avery,
Patrick M. Boland,
Joseph Chao,
Annals of Oncology · 2021 · 14 citations · 0 references